TALK. TEXT. SHARE.
LIVE

Serial Number

97530188

Owner

Optiks Solutions, Inc

Attorney

Erin C Bray

First Use Date

May 10, 2022

Filing Date

Aug 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

TALK. TEXT. SHARE. Trademark

Serial Number: 97530188 • Registration: 7281636

TALK. TEXT. SHARE. is a trademark filed by Optiks Solutions, Inc on August 2, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Optiks Solutions, Inc (15 trademarks)

343 Thornall Street, Suite 660
Edison, NJ 08837

Entity Type: 03

Trademark Details

Filing Date

August 2, 2022

Registration Date

January 16, 2024

First Use Anywhere

May 10, 2022

First Use in Commerce

May 10, 2022

Goods & Services

Platform as a service (PAAS) featuring computer software platforms for IT Solutions for Healthcare, Medical Devices, pharmaceutical and biotech industries, namely, Mobile Application to Record Interactions with Healthcare Professionals, patients, healthcare organizations Including Physicians, Patients, Payers, Providers and Providing Representatives an Ability to View Media Content and Reports, Web and Mobile Portals For Patients to Find Information on Drugs and Connect with Pharma Companies, Web and Mobile Portals For Physicians to Find Information on Drugs and Connect with Pharma Companies, Mobile and Web Application to Providing Reporting and Analytics Capabilities Using Various Data Sources; Providing temporary use of non-downloadable cloud based software featuring computer software platforms for IT Solutions for Healthcare, Medical Devices pharmaceutical and biotech industries, namely, Sales Force Automation to log interactions with health care professionals including physicians, Patients, Payers, Providers, Customer Relationship Management application to manage Contacts, Accounts, Opportunities, Orders and other custom entities, Maintain operational customer master and integrate with other applications, Application to manage all phases of clinical trials including Site Management and Study Management, Application to provide patients with complete support during the course of therapy from the time of prescription including welcome call, Benefit Investigations, Trial Orders, Prior Authorization; Providing temporary use of online non-downloadable Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma, biotech, and med devices companies, physicians, payers, and providers; software as a service (SAAS) services featuring Analytics and Planning software providing advanced analytics using machine learning, Internet of Things (IoT), and artificial intelligence to support interactions between pharma/biotech/med devices companies, physicians, payers, and providers; Platform as a service (PAAS) featuring conversational artificial intelligence for call filtering, call monitoring, making audio and video calls, co-browse, SMS and email alerts, sales tracking, attribution measurement, marketing and sales optimization, and customer service to support interactions between pharmaceuticals, biotechnology, and medical devices companies, physicians, patients, payers, and providers, and other healthcare workers; Software as a Services (SAAS) featuring conversational artificial intelligence for call filtering, call monitoring, making audio and video calls, co-browse, SMS and email alerts, sales tracking, attribution measurement, marketing and sales optimization, and customer service to support interactions between pharmaceuticals, biotechnology, and medical devices companies, physicians, patients, payers, and providers, and other healthcare workers

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 22, 2024 NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 17, 2024 NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jan 16, 2024 R.SR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Aug 24, 2023 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 20, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 20, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 20, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 20, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 20, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 20, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2023 CNRT
ASSIGNED TO EXAMINER
May 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 23, 2022 NWOS
NEW APPLICATION ENTERED
Aug 5, 2022 NWAP